ABBOTT LABORATORIES Other Non-current Liabilities 2007-2025 | ABT
Beta
What is ABBOTT LABORATORIES's current other non-current liabilities?
ABBOTT LABORATORIES (ABT) annual other non-current liabilities for 2025 was $2.54B, a 1.86% decline from 2024. ABBOTT LABORATORIES other non-current liabilities for the quarter ending December 31, 2025 was $2.54B.
What was ABBOTT LABORATORIES's other non-current liabilities in 2024?
ABBOTT LABORATORIES annual other non-current liabilities for 2024 was $2.59B, a 25.39% decline from 2023.
What was ABBOTT LABORATORIES's other non-current liabilities in 2023?
ABBOTT LABORATORIES annual other non-current liabilities for 2023 was $3.47B, a 8.89% decline from 2022.
What is ABBOTT LABORATORIES's 4-year other non-current liabilities CAGR?
ABBOTT LABORATORIES other non-current liabilities grew at a compound annual growth rate (CAGR) of 8.90% from FY2021 to FY2025, going from $3.69B to $2.54B over 4 years.
Other Non-current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-22.4%
FY2017
$9.03B
→
FY2025
$2.54B
07080910111213141516172122232425
5 years selected
Other Non-current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.54B | -1.9% | 10-K |
| FY2024 | $2.59B | -25.4% | 10-K |
| FY2023 | $3.47B | -8.9% | 10-K |
| FY2022 | $3.80B | +3.2% | 10-K |
| FY2021 | $3.69B | -59.2% | 10-K |
| FY2017 | $9.03B | +98.5% | 10-K |
| FY2016 | $4.55B | -6.5% | 10-K |
| FY2015 | $4.86B | -13.1% | 10-K |
| FY2014 | $5.60B | +17.1% | 10-K |
| FY2013 | $4.78B | -47.2% | 10-K |
| FY2012 | $9.06B | +10.0% | 10-K |
| FY2011 | $8.23B | +2.6% | 10-K |
| FY2010 | $8.02B | +58.0% | 10-K |
| FY2009 | $5.08B | +10.5% | 10-K |
| FY2008 | $4.60B | +39.3% | 10-K |
| FY2007 | $3.30B | - | 10-K |
Company: ABBOTT LABORATORIESTicker: ABTSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →